An infusion center's scheduling problem isn't a generic appointment calendar problem. Chair or bay time has to be booked against actual infusion duration, which varies wildly by drug and protocol, and a general oncology EHR's scheduling module often treats every visit as the same length slot, which is exactly how a center ends up with a four-hour infusion double-booked against a thirty-minute one.
Most infusion centers either run on a general oncology EHR that handles clinical documentation well but schedules chairs poorly, or a scheduling add-on that doesn't talk to billing and 340B drug-reimbursement tracking cleanly. We start from your actual chair or bay count, your protocol mix, and whether 340B reimbursement is a meaningful part of your revenue, then match the system to that instead of whichever EHR your affiliated practice already runs. Getting there means your scheduling templates, drug-protocol duration data, and billing history need to move in correctly, and if your center's protocol mix or 340B tracking doesn't fit cleanly into a standard scheduling-and-billing setup, we build the logic that actually represents how your chairs and your reimbursement really work.
A general oncology EHR's scheduling module usually treats every visit as a roughly equal slot, which doesn't represent how infusion duration actually varies by drug and protocol. We check whether a platform's scheduling logic genuinely accounts for real infusion length against your actual chair count before recommending it.
Drug-protocol duration templates, scheduling history, and billing records, including 340B reimbursement tracking where it applies, need to move into the new system correctly so a chair's schedule doesn't have to be rebuilt from scratch on go-live day.
A center drawing meaningful revenue from 340B drug reimbursement, or running a protocol mix that doesn't map onto a standard scheduling template, sometimes finds the gap between clinical scheduling and billing reconciliation has to be closed manually. We build that reconciliation logic in instead of leaving staff to track it outside the system.
Your actual chair or bay count, your protocol mix, and whether 340B reimbursement is a real part of your revenue decide this more than which EHR your affiliated practice already runs. Walk us through how your center actually schedules and bills and we'll tell you honestly which platform fits, what a real migration looks like, or whether your protocol mix needs something built custom.
Get a free quote → →Sometimes, but it's worth checking specifically rather than assuming. A lot of oncology EHRs are built primarily around clinical documentation and treat scheduling as a secondary module that doesn't fully account for real infusion-duration variance, which is exactly the gap we check for.
Yes, if migrated properly, which is what we do before any cutover. We move scheduling templates and billing history in so your chairs aren't starting from a blank schedule on day one.
Some do natively, many treat it as a manual reconciliation step outside the core system, which matters a lot if 340B is a meaningful part of your revenue. We check this specifically before recommending anything.
Yes, meaningfully. A platform that handles one dominant protocol length well can struggle to represent a genuinely wide mix accurately, which is exactly what we weigh before narrowing the field.
We do. The software vendors maintain their own platform; migrating your scheduling templates and billing history, and building custom 340B or protocol-mix logic when the standard setup doesn't fit, is our work.
Picking usually takes a couple of weeks once we understand your chair count and protocol mix. The migration itself typically takes four to six weeks depending on billing history and scheduling complexity.